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Resting heart rate is an independent predictor of colorectal cancer (CRC) development and
CRC-related mortality. However, little is known about the relationship between resting heart
rate and colorectal adenoma development. We aimed to investigate this association in a
population who underwent screening colonoscopy.
Methods
Among 39,021 patients who underwent both electrocardiogram and screening colonoscopy
during routine health examinations at the Seoul National University Bundang Hospital, Health
Promotion Center, Korea from January 2014 to July 2019, 1,344 patients had advanced ade-
noma. We performed 1:1 propensity score (PS) matching to establish a control group that
mitigated the confounding effects of age and sex. We performed multivariate logistic regres-
sion analyses to identify the independent risk factors of advanced adenoma development.
Results
Resting heart rate was significantly higher in the advanced adenoma group than in the con-
trol group. The prevalence of advanced polyp increased across the quartiles of resting heart
rate. Patients with higher resting heart rates were more likely to be older, smokers, and have
increased blood pressure and DM and less likely to engage in active exercises than those
with lower resting heart rates. Patients with higher resting heart rates had higher serum glu-
cose, triglyceride, hemoglobin A1C, and insulin levels and lower high-density lipoprotein
cholesterol levels. Patients with resting heart rate in the highest quartile (�71 bpm) still
showed significantly increased odds ratio (OR) of advanced adenoma development (OR:
1.379, 95% confidence interval: 1.099–1.731, p = 0.006).
Conclusions
High resting heart rate was a meaningful independent risk factor of advanced adenoma
development.
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Introduction
Colorectal advanced adenoma is defined as a colorectal polyp with a diameter>1 cm, or pres-
ence of�3 adenomas per patient, and/or villous component, and/or severe dysplasia, predict-
ing an increased likelihood of malignant transformation [1]. The prevalence of advanced
adenoma ranged from 2.5% to 9.7% in the normal population [2]. Advanced adenoma has
been regarded as a surrogate for colorectal cancer (CRC) in the adenoma-carcinoma pathway.
Screening colonoscopy is recommenced for identifying and removing adenomas, particularly
advanced adenomas. The development of CRC could be prevented by identifying the risk fac-
tors for advanced adenoma and actively performing screening colonoscopy for high-risk
patients. Advanced adenoma development is strongly associated with old age, male sex, family
history of CRC, cigarette smoking, obesity, and hyperglycemia in the previous studies [3–5]..
Resting heart rate has been suggested to be an important predictor of all-cause mortality,
cardiovascular mortality, and cancer mortality [6–9]. Resting heart rate is an independent pre-
dictor of death in patients with CRC, pancreatic cancer, and non-small cell lung cancer [10].
Although the resting heart rate was not related to the overall cancer incidence in patients with
vascular disease in a previous study, an increasing trend in resting heart rate was seen in
patients with CRC development (hazard ratio [HR]: 1.19, 95% confidence interval [CI]: 1.00–
1.42) [11]. Moreover, patients with CRC have a significantly higher resting heart rate than the
cancer-free controls [12]. Moreover, several studies have demonstrated the protective effect of
beta-blockers against cancer progression [13,14]. However, little is known about the relation-
ship between resting heart rate and colorectal adenoma development.
A previous study reported a high resting heart rate associated with a significantly increased
risk for advanced adenoma recurrence as detected by surveillance colonoscopy in CRC
patients [15]. However, the study had a relatively small sample size and few cases of advanced
adenoma recurrence (n = 27). Moreover, the resting heart rate was measured at the outpatient
visit in a sitting position in the previous studies [12,15]. The present study aimed to assess the
relationship between resting heart rate measured by an electrocardiogram (ECG) and
advanced adenoma development in a population who underwent screening colonoscopy.
Methods
Patients and study design
We analyzed 39,021 patients who underwent both ECG and screening colonoscopy during
routine health examinations at the Seoul National University Bundang Hospital, Health
Promotion Center, Korea from January 2014 to July 2019. We excised all polyps detected dur-
ing colonoscopy, and all specimens were sent to the pathology department for histological
evaluation. Colorectal advanced adenoma was defined as a colorectal polyp with a diameter
of>1 cm, or presence of�3 adenomas per patient, and/or villous component, and/or severe
dysplasia based on the pathology specimens. A total of 1,344 patients had advanced adenoma
in the present study. The study population was composed of 1,016 men (75.6%) and 328
women (24.4%). We performed 1:1 propensity score (PS) matching to establish control group
without colon polyps that mitigated the confounding effects of age and sex. The exclusion cri-
teria were as follows: patients with (i) incomplete medical records, (ii) a history of familial pol-
yposis syndrome or Lynch syndrome, and (iii) known inflammatory bowel disease (IBD). This
study was approved by the Institutional Review Board of Seoul National University Bundang
Hospital, and the requirement for obtaining written informed consent from the patients was
waived.
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inflammatory bowel disease; LDL, low-density
lipoprotein; MMP 6, metalloproteinase 6; OR, odds
ratio; PS, propensity score; TG, triglyceride; VEGF,
vascular endothelial growth factor; WHO, World
Health Organization.
Data collection
Resting heart rate was assessed by 12-lead ECG in a supine position after>10 min of sufficient
rest in all patients at the time of screening colonoscopy. Blood pressure was measured in a sitting
position using an upper arm cuff oscillometric blood pressure device. The patients were instructed
to avoid eating, drinking alcohol, smoking, exercising, and bathing for 30 min before the measure-
ment. Height and weight were measured by trained nurses. Body mass index (BMI) was calculated
as weight in kilograms divided by the square of height in meters. The BMI was categorized follow-
ing the World Health Organization (WHO) Asia-Pacific classification as normal (BMI<25.0 kg/
m2) and obese (BMI�25 kg/m2) [16]. Data on physical activity, alcohol consumption, smoking
status, and family history of CRC were obtained using self-reported questionnaires. Hypertension
(HTN), diabetes mellitus (DM), dyslipidemia, coronary artery disease, peripheral artery disease,
cerebrovascular disease, and arrhythmia were defined as the use of medications or “diagnosed by
a physician”. Blood sampling was obtained the morning after an overnight fast. Plasma glucose,
total cholesterol, triglyceride (TG), low-density lipoprotein (LDL) cholesterol, high-density lipo-
protein (HDL) cholesterol, hemoglobin A1C (HbA1C), and insulin levels were obtained.
Statistical analyses
The means and standard deviations or medians and ranges were calculated for all continuous
variables, as appropriate. Categorical variables were expressed as proportions (%), and statisti-
cal analyses were performed to compare the variables between groups. Independent two-sam-
ple t-test or one-way analysis of variance (ANOVA) tests were used to compare continuous
variables. Chi-square tests were used for categorical variables, as appropriate. We conducted
an univariable logistic regression analysis for all variables. The variables which achieved a p-
value < 0.05 after univariable logistic regression analysis were exported to the multivariable
logistic regression analysis. Multivariate logistic regression analyses were carried out to iden-
tify the independent risk factors of advanced adenoma development, with adjustment for vari-
ous confounders, including age, sex, alcohol history, smoking history, family history of CRC,
exercise, BMI, HTN, DM, dyslipidemia, coronary artery disease, peripheral artery disease,
cerebrovascular disease, arrhythmia, systolic blood pressure, and diastolic blood pressure. All
statistical analyses were performed using the Statistical Package for Social Sciences (SPSS ver-
sion 23.0; SPSS Inc., Armonk, NY, USA). The PS matching to establish control group without
colon polyps that mitigated the confounding effects of age and were performed by R package
(version 3.2.2). A p-value of<0.05 was considered statistically significant. All authors had
access to the study data and reviewed and approved the final manuscript.
Results
Baseline characteristics
Screening colonoscopy was performed on 39,021 patients from January 2014 to July 2019 at
the Seoul National University Bundang Hospital, Health Promotion Center, Korea. Of the
t39,021 patients, 19,826 (50.8%) patients had colorectal polyps. Moreover, 1,344 (3.4%)
patients had advanced adenomas.
The baseline characteristics of the advanced adenoma patients (n = 1344) and PS-matched con-
trols (n = 1344) were investigated (Table 1). The advanced adenoma group had a higher proportion
of patients who were smoking, engaging in less physical activity, with a higher BMI of>25 kg/m2,
and with HTN, DM, peripheral artery disease, and cerebrovascular disease. Regarding the metabolic
parameters, serum glucose, TG, hemoglobin A1C, and insulin levels were higher, and serum HDL
cholesterol levels were lower in the advanced adenoma group than in the control group.
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Baseline characteristics according to the resting heart rates
The baseline characteristics of the study participants according to quartiles of the resting heart
rate are shown in Table 2. Patients with higher resting heart rates were more likely to be youn-
ger (p trend = 0.020), to be smokers (p trend = 0.040), to engage in less active exercise (p
trend = 0.001), to have higher systolic blood pressure (p trend = 0.027), to have higher diastolic
blood pressure (p trend < 0.001), and to have DM (p trend< 0.001).
When the metabolic parameters among the groups are compared according to the resting
heart rate, significant differences in serum glucose (p trend< 0.001), TG (p trend < 0.001),
HDL-C (p trend = 0.002), HbA1C (p trend< 0.001), and insulin levels (p trend = 0.002) were
observed among the groups (Table 2). No significant difference was seen for total cholesterol
and LDL-C levels.
Advanced adenoma development rates according to the resting heart rates
Resting heart rate was significantly higher in the advanced adenoma group than in the control
group (66.6 ± 10.4 vs. 65.0 ± 10.0 bpm, p< 0.001). The prevalence of advanced polyp showed
an increasing tendency across the quartiles of resting heart rate (47.2% vs. 47.1% vs. 47.9% vs.
57.1%; p< 0.001; Table 3).
Table 1. Baseline characteristics of controls and advanced adenoma patients after 1:1 propensity score matching for age and gender.
Variables Control group (n = 1344) Advanced adenoma group (n = 1344) �p value
Age (years) 56.8 ± 9.8 56.8 ± 9.8 0.970
Males 1017 (75.7%) 1016 (75.6%) 1.000
Smoking history 498 (37.1%) 584 (43.5%) 0.001
Alcohol history 600 (44.6%) 614 (45.7%) 0.614
Family history of colorectal cancer 78 (5.8%) 78 (5.8%) 1.000
Active exercise 443 (33.0%) 392 (29.2%) 0.037
BMI (� 25kg/m2) 421 (35.2%) 569 (44.6%) < 0.001
Systolic blood pressure (mmHg) 119.7 ± 11.6 120.4 ± 12.5 0.190
Diastolic blood pressure (mmHg) 74.1 ± 9.1 74.3± 9.7 0.599
Medical history
HTN 359 (26.7%) 412 (30.7%) 0.027
DM 135 (10.0%) 197 (14.7%) < 0.001
Dyslipidemia 368 (27.4%) 405 (30.1%) 0.125
Coronary artery disease 56 (4.2%) 47 (3.5%) 0.422
Peripheral arterial disease 2 (0.1%) 12 (0.9%) 0.013
Cerebrovascular disease 13 (1.0%) 33 (2.5%) 0.004
Arrhythmia 9 (0.7%) 8 (0.6%) 1.000
Metabolic parameters
Serum glucose (mg/dL) 95.1 ± 19.5 99.8 ± 29.2 < 0.001
Total cholesterol (mg/dL) 196.6 ± 39.1 199.1 ± 63.4 0.223
Serum triglyceride (mg/dL) 109.8 ± 71.3 125.3 ± 91.8 < 0.001
Serum high-density lipoprotein (mg/dL) 53.4± 12.1 51.9 ± 12.6 0.002
Serum low-density lipoprotein (mg/dL) 120.9 ± 31.7 121.1 ± 32.0 0.902
Hemoglobin A1C (%) 5.8 ± 1.7 5.9 ± 0.9 0.045
Serum insulin 7.4 ± 3.6 8.4 ± 4.4 < 0.001
Variables are expressed as mean ± SD or n (%).
�p value when comparing the lower resting heart rate group with the higher resting heart rate group.
b.p.m., beats per minute; BMI, body mass index; DM, diabetes mellitus; SD, standard deviation.
https://doi.org/10.1371/journal.pone.0254505.t001
PLOS ONE Effect of heart rate on advanced adenoma
PLOS ONE | https://doi.org/10.1371/journal.pone.0254505 July 9, 2021 4 / 10
In the univariate analysis, the patients with resting heart rate in the highest quartile (>70
bpm) showed significantly increased odds ratio (OR) of advanced adenoma development,
compared to those with resting heart rate in the lowest quartile (�58 bpm.) (OR: 1.488, 95%
CI: 1.202–1.842, p< 0.001). After adjusting for age, the patients with resting heart rate in the
highest quartile showed a significantly increased OR of advanced adenoma development (OR:
1.489, 95% CI: 1.202–1.844, p< 0.001). After adjusting for multiple variables, the patients with
resting heart rate in the highest quartile still showed a significantly increased OR of advanced
adenoma development (OR: 1.379, 95% CI: 1.099–1.731, p = 0.006). Smoking history (OR:
1.287, 95% CI: 1.090–1.520, p = 0.003), high BMI of>25 kg/m2 (OR: 1.404, 95% CI: 1.190–
1.658, p< 0.001), and history of DM (OR: 1.391, 95% CI: 1.082–1.788, p = 0.010), peripheral
artery disease (OR: 4.873, 95% CI: 1.075–22.081, p = 0.040), and cerebrovascular disease (OR:
2.896, 95% CI: 1.403–5.979, p = 0.004) were also positively associated with an increased risk of
Table 2. Baseline characteristics of the study participants according to resting heart rates quartiles.
Advanced adenoma Quartile 1 34–58 b.p.m
(n = 642)
Quartile 2 59–64 b.p.m
(n = 665)
Quartile 3 65–70 b.p.m
(n = 654)




Age (� 60 years) 259 (40.3%) 254 (26.0%) 200 (20.5%) 263 (26.9%) 0.020
Males 489 (76.2%) 490 (73.7%) 478 (73.1%) 576 (79.2%) 0.198
Smoking history 252 (39.3%) 256 (38.5%) 246 (37.8%) 3327 (45.0%) 0.040
Alcohol history 289 (45.0%) 301 (45.3%) 283 (43.3%) 341 (46.9%) 0.632
Family history of colorectal cancer 35 (5.5%) 37 (5.6%) 38 (5.8%) 46 (6.3%) 0.467
Active exercise 228 (35.5%) 217 (32.6%) 184 (28.1%) 206 (28.3%) 0.001
BMI (� 25kg/m2) 234 (40.0%) 236 (38.1%) 230 (38.4%) 290 (43.4%) 0.199
Systolic blood pressure (mmHg) 119.2 ± 11.8 119.4 ± 11.6 120.1 ± 12.4 120.2 ± 12.1 0.027
Diastolic blood pressure (mmHg) 72.7 ± 9.2 73.9 ± 9.0 74.5 ± 9.5 75.6 ± 9.8 <
0.001
Medical history
Hypertension 184 (23.9%) 174 (22.6%) 182 (23.6%) 231 (30.0%) 0.134
DM 68 (10.6%) 72 (10.8%) 77 (11.8%) 115 (15.8%) 0.003
Dyslipidemia 178 (27.7%) 185 (27.8%) 178 (27.2%) 232 (31.9%) 0.108
Coronary artery disease 30 (4.7%) 26 (3.9%) 20 (3/1%) 27 (3.7%) 0.277
Peripheral arterial disease 0 (0.0%) 4 (0.6%) 2 (0.3%) 8 (1.1%) 0.014
Cerebrovascular disease 15 (2.3%) 6 (0.9%) 15 (2.3%) 10 (1.4%) 0.501
Arrhythmia 6 (0.9%) 3 (0.5%) 2 (0.3%) 6 (0.8%) 0.783
Metabolic parameters
Serum glucose (mg/dL) 94.7 ± 20.8 95.5 ± 18.1 97.8 ± 29.1 101.2 ± 28.9 <
0.001
Total cholesterol (mg/dL) 198.2 ± 81.4 197.8 ± 38.2 197.7 ± 38.9 197.7 ± 41.7 0.998




53.8 ± 13.2 53.1 ± 12.0 52.6 ± 12.6 51.3 ± 11.7 0.002
Serum low-density lipoprotein
(mg/dL)
119.7 ± 30.3 121.5 ± 30.4 121.9 ± 31.5 121.1 ± 34.7 0.654
Hemoglobin A1C (%) 5.8 ± 1.3 5.7 ± 0.6 5.7 ± 0.8 6.0 ± 2.2 <
0.001
Serum insulin 7.3 ± 3.7 7.8 ± 4.3 8.0 ± 4.0 8.4 ± 4.3 0.002
Variables are expressed as mean ± SD or n (%).
�p value when comparing quartile groups based on resting heart rates.
b.p.m., beats per minute; BMI, body mass index; DM, diabetes mellitus; SD, standard deviation.
https://doi.org/10.1371/journal.pone.0254505.t002
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advanced adenoma development (Table 4). Active exercise was negatively associated with the
development of advanced adenoma (OR: 0.804, 95% CI: 0.676–0.957, p = 0.014).
Discussion
Resting heart rate is known as an independent risk factor for all-cause mortality, cardiovascu-
lar mortality, cancer mortality, and CRC-related mortality [6–10]. Resting heart rate is also
Table 3. Advanced adenoma development rates according to resting heart rates.
Quartile 1 34–58 b.p.m
(n = 642)
Quartile 2 59–64 b.p.m
(n = 665)
Quartile 3 65–70 b.p.m
(n = 654)
Quartile 4 71–138 b.p.m
(n = 727)
p trend
Event 303 (47.2%) 313 (47.1%) 313 (47.9%) 415 (57.1%) <
0.001
Univariate 1.000 (reference) 0.995 (0.801–1.236) 1.027 (0.826–1.277) 1.488 (1.202–1.842)�
Age-adjusted 1.000 (reference) 0.995 (0.801–1.237) 1.028 (0.826–1.279) 1.489 (1.202–1.844)�
Multivariable-
adjusteda
1.000 (reference) 0.971 (0.773–1.221) 0.981 (0.779–1.236) 1.379 (1.099–1.731)�
Variables are expressed as n (%).
b.p.m., beats per minute.
a Adjusted for age, sex, history of alcohol, history of smoking, family history of colorectal cancer, exercise, body mass index, hypertension, diabetes melliatus,
dyslipidemia, coronary artery disease, peripheral artery disease, cerebrovascular disease, arrhythmia, systolic blood pressure, and diastolic blood pressure.
� p < 0.05.
https://doi.org/10.1371/journal.pone.0254505.t003
Table 4. Logistic regression analysis for advanced adenoma development.
Variables Univariate analysis Multivariate analysis
OR 95% CI �p value OR 95% CI �p value
Age 1.000 0.992–1.008 0.970
Sex 1.004 0.842–1.197 0.964
Smoking history 1.305 1.118–1.524 0.001 1.287 1.090–1.520 0.003
Alcohol history 1.043 0.896–1.214 0.587
Family history of colorectal cancer 1.000 0.724–1.382 1.000
Active exercise 0.837 0.711–0.986 0.034 0.804 0.676–0.957 0.014
Body Mass Index (�25kg/m2) 1.484 1.262–1.745 <0.001 1.404 1.190–1.658 < 0.001
Hypertension 1.213 1.026–1.434 0.024 1.116 0.932–1.338 0.233
Diabetes Mellitus 1.538 1.218–1.943 <0.001 1.391 1.082–1.788 0.010
Hyperlipidemia 1.144 0.968–1.352 0.115
Coronary artery disease 1.011 0.775–1.319 0.935
Peripheral artery disease 6.063 1.354–27.143 0.018 4.873 1.075–22.081 0.040
Cerebrovascular disease 2.585 1.355–4.934 0.004 2.896 1.403–5.979 0.004
Arrhythmia 0.891 0.343–2.316 0.813
Resting heart rates
Quartile 1 1.000 Reference 1.000 Reference
Quartile 2 0.995 0.801–1.236 0.963 0.971 0.773–1.221 0.804
Quartile 3 1.027 0.826–1.277 0.811 0.981 0.779–1.236 0.873
Quartile 4 1.488 1.202–1.842 <0.001 1.379 1.099–1.731 0.006
Systolic blood pressure (mmHg) 1.005 0.998–1.011 0.190
Diastolic blood pressure (mmHg) 1.002 0.994–1.011 0.599
�p value when comparing the advanced adenoma group and the non-advanced adenoma group.
OR, odds ratio; CI, confidence interval.
https://doi.org/10.1371/journal.pone.0254505.t004
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related to CRC development and advanced adenoma recurrence in CRC patients, as reported
in previous studies [11,12,15]. The cross-sectional nature of our study precludes a causal infer-
ence between resting heart rate and the risk of developing colorectal adenoma. However, our
results might suggest that the high resting heart rate could be implicated in the development of
colorectal advanced adenoma through the process of CRC carcinogenesis.
One possible mechanism explaining the decreased risk for advanced adenoma development
by active exercise might be the mediating effect of the resting heart rate. Active exercise could
increase in resting parasympathetic tone, decrease in response to beta-adrenergic stimulation,
and contribute to a decrease in resting heart rates [17]. The most effective way for lowering the
resting heart rate is by engaging in regular active exercises, and active exercises could prevent
CRC development and recurrence [18,19]. The resting heart rate was significantly lower in the
active exercise group than in the sedentary group in the present study. Moreover, there were
more active patients in the lower resting heart rate quartiles. Nevertheless, after adjusting for
multiple variables, including active exercise, the patients with resting heart rate in the highest
quartile still showed significantly increased OR of advanced adenoma development, suggesting
that the high resting heart rate is not only a marker of lack of physical activity but also an inde-
pendent risk factor of advanced adenoma development.
The patients with high resting heart rates were more likely to be smokers. Linneberg et al.
demonstrated that smoking heaviness has a causal relationship with a high resting heart rate
[20]. Smoking could be the mediating effect of resting heart rate in advanced adenoma devel-
opment. The mechanism of increased resting heart rate related to smoking is unclear. Nicotine
could increase the resting heart rate owing to the release of norepinephrine and epinephrine
[21]. Smoking could reflect persistent sympathetic nervous stimulation and lead to autonomic
dysfunction [22]. Given that smoking cessation is known to decrease the resting heart rate in a
previous study, not only active exercise but also smoking cessation could prevent the develop-
ment of advanced adenoma by decreasing the resting heart rate [23].
The resting heart rate is significantly associated with the presence of metabolic syndrome
[24]. DM, insulin resistance, hyperinsulinemia, and metabolic syndrome have been reported
as risk factors of colorectal advanced adenoma and CRC development [25,26]. In our study,
the patients with a high resting heart rate showed an increased incidence of DM, increased
serum glucose, TG, HbA1C, and insulin levels, and decreased HDL-C levels. The presence of
poor metabolic parameters could be related to the increased resting heart rate and advanced
adenoma development.
The resting heart rate could be corrected through lifestyle modification, including engaging
in active exercises and cessation of smoking, which could eventually improve the metabolic
parameters. Many previous studies investigated the effect of beta blockers, because of the
weakened norepinephrine signaling in CRC patients. Some studies reported the protective
effects of beta blockers in CRC patients [27–29] Beta blockers decreased the proliferation of
colorectal cancer cells by inhibiting adrenergic activations [30]. Engineer et al. observed an
association between exposure to a combination of angiotensin-converting enzyme inhibitors
and beta blockers and increased survival, decreased length of hospitalization, and decreased
tumor progression in advanced CRC patients [31]. However, Jansen et al. reported no associa-
tion between beta blocker use and CRC development after adjusting for covariates in a large
population-based CRC cohort [32]. The clinical application of beta blockers as therapeutic
agents for CRC is putative, but adrenergic hyperactivity is considered an important risk factor
in CRC pathogenesis. Coetho et al. reported that some beta blockers, including propranolol,
carvedilol, and atenolol, significantly decreased the proliferation of human CRC cells [30]. In
summary, the resting heart rate is a factor that could be modified by improving the lifestyle,
such as engaging in aerobic exercises, regular sleep cycle, and smoking and alcohol drinking
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cessation [33–35]. Furthermore, healthy lifestyle aimed at controlling the resting heart rate
could reduce both incidence of and mortality from various metabolic diseases, cardiovascular
diseases, advanced adenoma, and CRC.
This study has several limitations. First, we are unable to explain the causal relationship
between resting heart rate and advanced adenoma development because of the study’s retro-
spective, cross-sectional, and case-control design. Second, we only analyzed a single measure-
ment of the resting heart rate and metabolic parameters; we did not perform repeated
measurements of these parameters. Nevertheless, we obtained the accurate resting heart rate
by 12-lead ECG in a supine position after >10 minutes of sufficient rest in all patients. Third,
the measurement of the resting heart rate could be influenced by multiple factors. Fourth, the
heart rate variability, linked to cancer prognosis and survival, was not investigated in this
study [36,37]. Fifth, we have matched controls based on age and sex, not on potential con-
founders, such as BMI and smoking. Despite these limitations, the strength of the study is the
inclusion of a large number of patients with histologically confirmed colorectal advanced ade-
nomas who underwent health screening examinations; thus, our cohort may be representative
of the general population. Moreover, many confounders, such as alcohol and smoking history,
obesity, physical activity, and metabolic laboratory data were available.
In conclusion, the resting heart rate was positively associated with the development of
advanced adenoma in patients who underwent screening colonoscopy during routine health
examinations. Patients with high resting heart rates were more likely to be smokers, to be
engaging in less active exercises, and to have DM. We consider that healthy lifestyle modifica-
tions aimed at controlling the resting heart rate could decrease the risk of developing advanced
adenoma.
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